ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Zengli Fang
Matched on OpenAlex author ID A5058522614. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers
Papers 3
- Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT. First author DOI 10.1016/j.csbj.2023.04.003↗
- Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Prelimin… Co-author DOI 10.3390/curroncol30030228↗
- Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.18632/aging.202199↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qingcai Meng · 3 shared papers, 2020–2023 · strength 0.46
- Paper Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogenei… DOI 10.1016/j.csbj.2023.04.003↗
- Paper Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration … DOI 10.3390/curroncol30030228↗
- Paper Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis. DOI 10.18632/aging.202199↗
- Jie Hua · 3 shared papers, 2020–2023 · strength 0.46
- Paper Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogenei… DOI 10.1016/j.csbj.2023.04.003↗
- Paper Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration … DOI 10.3390/curroncol30030228↗
- Paper Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis. DOI 10.18632/aging.202199↗
- Jin Xu · 3 shared papers, 2020–2023 · strength 0.46
- Paper Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogenei… DOI 10.1016/j.csbj.2023.04.003↗
- Paper Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration … DOI 10.3390/curroncol30030228↗
- Paper Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis. DOI 10.18632/aging.202199↗
- Xianjun Yu · 3 shared papers, 2020–2023 · strength 0.46
- Paper Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogenei… DOI 10.1016/j.csbj.2023.04.003↗
- Paper Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration … DOI 10.3390/curroncol30030228↗
- Paper Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis. DOI 10.18632/aging.202199↗
- Si Shi · 3 shared papers, 2020–2023 · strength 0.46
- Paper Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogenei… DOI 10.1016/j.csbj.2023.04.003↗
- Paper Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration … DOI 10.3390/curroncol30030228↗
- Paper Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis. DOI 10.18632/aging.202199↗
- Wei Wang · 2 shared papers, 2023 · strength 0.35
- Paper Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogenei… DOI 10.1016/j.csbj.2023.04.003↗
- Paper Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration … DOI 10.3390/curroncol30030228↗
- Chen Liang · 2 shared papers, 2020–2023 · strength 0.28
- Xiaoqi Mao · 1 shared paper, 2023 · strength 0.18
- Liang Chen · 1 shared paper, 2023 · strength 0.18
- Rong Tang · 1 shared paper, 2023 · strength 0.18
- Bo Zhang · 1 shared paper, 2023 · strength 0.17
- Bo Zhang · 1 shared paper, 2020 · strength 0.11
- Wei Ting Wang · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.